Stockscreener 앱 받기
163.86
1.64%
-2.73
시간 외 거래:
163.86
전일 마감가:
$166.59
열려 있는:
$166.41
하루 거래량:
450.29K
Relative Volume:
0.53
시가총액:
$9.22B
수익:
$633.51M
순이익/손실:
$-8.10M
주가수익비율:
-528.58
EPS:
-0.31
순현금흐름:
$131.26M
1주 성능:
-1.09%
1개월 성능:
-4.19%
6개월 성능:
+31.74%
1년 성능:
+13.84%
1일 변동 폭
$163.47
$167.09
1주일 범위
$161.41
$167.65
52주 변동 폭
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
명칭
Repligen Corp
전화
(781) 449-9560
주소
41 SEYON STREET, WALTHAM, MA
RGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
163.86 | 9.38B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
566.36 | 203.00B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
194.07 | 55.74B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.81 | 38.96B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
240.87 | 35.48B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 33.00B | 27.43B | 1.27B | 1.01B | 1.5829 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-01 | 개시 | HSBC Securities | Buy |
| 2025-09-22 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-29 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 개시 | Evercore ISI | In-line |
| 2025-02-10 | 개시 | TD Cowen | Buy |
| 2024-12-17 | 개시 | Canaccord Genuity | Hold |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 개시 | Guggenheim | Neutral |
| 2023-12-04 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 개시 | Wells Fargo | Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-03-28 | 개시 | The Benchmark Company | Buy |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2021-10-14 | 개시 | Exane BNP Paribas | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-23 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-11-01 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 개시 | SVB Leerink | Outperform |
| 2019-08-28 | 재확인 | First Analysis Sec | Outperform |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2019-07-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | 업그레이드 | CL King | Neutral → Buy |
| 2018-11-12 | 다운그레이드 | CL King | Buy → Neutral |
| 2018-09-26 | 개시 | H.C. Wainwright | Neutral |
| 2017-12-08 | 개시 | Citigroup | Buy |
| 2017-12-05 | 개시 | JP Morgan | Overweight |
| 2017-11-13 | 개시 | CL King | Buy |
| 2017-10-02 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 개시 | William Blair | Outperform |
| 2017-02-13 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
Repligen Corp 주식(RGEN)의 최신 뉴스
Repligen Corporation (NASDAQ:RGEN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Why Repligen Corporation stock remains undervaluedFibonacci Retracement Levels & Free Dynamic Capital Growth - bollywoodhelpline.com
Is Repligen (RGEN) Quietly Recasting Its Gene Therapy Moat With New HiPer Viral Vector Resins? - simplywall.st
Riverbridge Partners LLC Sells 24,644 Shares of Repligen Corporation $RGEN - MarketBeat
Congress Asset Management Co. Boosts Stake in Repligen Corporation $RGEN - MarketBeat
Assenagon Asset Management S.A. Takes Position in Repligen Corporation $RGEN - MarketBeat
Can Repligen Corporation stock maintain growth trajectoryFed Meeting & Smart Allocation Stock Tips - Улправда
Texas Permanent School Fund Corp Has $3.13 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Will Repligen Corporation stock rally after Fed decisions2025 Winners & Losers & Free Technical Pattern Based Buy Signals - Улправда
Why Repligen Corporation (RGN) stock trades below fair valueJuly 2025 Drop Watch & Risk Managed Investment Signals - Bölüm Sonu Canavarı
Repligen (RGEN): Assessing Valuation After New Chromatography Resins Expand Its Gene Therapy Toolkit - simplywall.st
How institutional buying supports Repligen Corporation stockJuly 2025 Highlights & High Accuracy Investment Signals - Улправда
Insider Sell: Karen Dawes Sells Shares of Repligen Corp (RGEN) - GuruFocus
Repligen (NASDAQ:RGEN) Director Karen Dawes Sells 275 Shares - MarketBeat
REPLIGEN Director Karen A Dawes Sells 275 Shares - TradingView — Track All Markets
[Form 4] REPLIGEN CORP Insider Trading Activity - Stock Titan
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference - Yahoo Finance
Here’s Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN) - Insider Monkey
The Bull Case For Repligen (RGEN) Could Change Following New Gene Therapy Chromatography Resin Launches - simplywall.st
Repligen (RGEN) Expands Product Line with High-Performance Chrom - GuruFocus
Repligen Corporation Launches Three New High-Performance Chromatography Resins to Enhance Bioprocessing Solutions - Quiver Quantitative
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows - Yahoo Finance
RGEN: Wells Fargo Raises Repligen's Price Target to $190 | RGEN Stock News - GuruFocus
Repligen Corporation $RGEN Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Repligen Corporation $RGEN Shares Purchased by Squarepoint Ops LLC - MarketBeat
Holocene Advisors LP Reduces Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Ranger Investment Management L.P. Has $20.89 Million Holdings in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Purchased by First Trust Advisors LP - MarketBeat
What's Driving the Market Sentiment Around Repligen Corp? - Benzinga
The five-year earnings decline is not helping Repligen's (NASDAQ:RGEN share price, as stock falls another 3.3% in past week - Yahoo Finance
London & Capital Asset Management Ltd Lowers Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Norges Bank Buys New Holdings in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Sold by Baird Financial Group Inc. - MarketBeat
Nothing is Better Than Repligen Corp (RGEN) stock at the moment - setenews.com
Does Repligen Corporation (RGN) stock trade below intrinsic value2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Brown Capital Management LLC Has $125.04 Million Position in Repligen Corporation $RGEN - MarketBeat
State Street Premier Growth Equity V.I.S. Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Why Repligen Corporation stock is rated strong buyRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Schroder Investment Management Group Makes New $25.67 Million Investment in Repligen Corporation $RGEN - MarketBeat
Edgestream Partners L.P. Makes New $3.48 Million Investment in Repligen Corporation $RGEN - Defense World
RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan
Repligen Corporation (NASDAQ:RGEN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Repligen Corporation (NASDAQ:RGEN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Loomis Sayles & Co. L P Acquires New Holdings in Repligen Corporation $RGEN - MarketBeat
Is Repligen Corporation stock attractive for hedge fundsPortfolio Value Report & Fast Moving Stock Trade Plans - Newser
Will Repligen Corporation stock outperform Nasdaq indexJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
How Repligen Corporation (RGN) stock reacts to new regulationsJuly 2025 Technicals & Real-Time Volume Triggers - Newser
Advisors Asset Management Inc. Cuts Holdings in Repligen Corporation $RGEN - Defense World
Rhumbline Advisers Lowers Holdings in Repligen Corporation $RGEN - MarketBeat
Coldstream Capital Management Inc. Sells 321 Shares of Repligen Corporation $RGEN - Defense World
American Century Companies Inc. Sells 2,253 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corp (RGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Repligen Corp 주식 (RGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MUIR GLENN P | Director |
Dec 16 '25 |
Option Exercise |
26.12 |
3,366 |
87,920 |
36,622 |
1.26%
0.19%
자본화:
|
볼륨(24시간):